---
name: Codis
slug: codis
site: cdmo
website_domain: codis.com
summary: Global CDMO specializing in commercial-scale spray drying, amorphous solid dispersions, microencapsulation, and continuous granulation with 400,000 sq ft of GMP manufacturing across US and UK facilities. Headquartered in St. Louis, United States.
tagline: Particle engineering and spray drying CDMO delivering commercial-scale manufacturing with 30 years of regulatory excellence.
founded_year: 
employee_count_band: 
employee_count_label: 
parent_name: 
parent_slug: 
hq_country: US
tier2_domain_verified: false
updated_at: 2026-08-05T00:02:46.731Z
services_count: 8
modalities_count: 1
indications_count: 0
locations_count: 5
review_signal_gate: closed
generated_by: BioBM Editorial AI
---

# Codis

Particle engineering and spray drying CDMO delivering commercial-scale manufacturing with 30 years of regulatory excellence.

Listed on cdmo.directory.

## Summary

Global CDMO specializing in commercial-scale spray drying, amorphous solid dispersions, microencapsulation, and continuous granulation with 400,000 sq ft of GMP manufacturing across US and UK facilities. Headquartered in St. Louis, United States.

## At a glance

- HQ country: US

## Services

- Formulation Development
- Process Development
- CMC Analytical Development
- Stability Testing & Storage
- Quality Control Testing
- CMC Regulatory Submission Support
- Oral Solid Dosage Manufacturing
- Secondary Packaging & Labeling

## Modalities

- Small Molecule

## Locations

- Headquarters, St. Louis, Missouri, USA
- Microencapsulation & Continuous Granulation, St. Louis, Missouri, USA
- Spray Drying & Commercial Manufacturing, Haverhill, England, UK
- Manufacturing Facility, Nottingham, England, UK
- Manufacturing Facility, Seymour, Indiana, USA

## Certifications

- FDA; Identifier: 21 CFR 210/211, 110/111, 117; Source: https://codis.com/facilities
- German Authorities; Identifier: Manufacturing site GMP approval (Pharmaceutical Products Act); Source: https://codis.com/quality

## Long description

## Overview

Codis is a global contract development and manufacturing organization (CDMO) specializing in particle engineering, spray drying, and formulation expertise. Formed through the integration of Particle Dynamics (US) and the Haverhill spray drying facility previously operated by EUROAPI, Codis combines decades of regulatory expertise and manufacturing strength under one brand.

## Core Capabilities

**Spray Drying & Amorphous Solid Dispersions (ASD)**
- Commercial-scale solvent-based and aqueous-based spray drying
- Industry-leading expertise in designing, scaling, and manufacturing amorphous solid dispersions for improved bioavailability of poorly soluble compounds
- One of the largest GMP spray drying capacities globally across US and UK facilities

**Microencapsulation**
- Proprietary solvent-free microencapsulation processes using spinning disc technology
- Enhanced taste masking, stability, and controlled release capabilities
- Applications in pharmaceutical, consumer health, OTC, and nutraceutical sectors

**Continuous Granulation**
- High-shear, aqueous-based continuous granulation system
- Ideal for large-volume continuous mixing, coating, hydrating, and homogenizing applications
- Tight particle size control and scalable performance in oral solid dosage formulations

**Final Dosage Forms & Secondary Services**
- Nutraceutical finished dosage form capabilities
- Labeling and secondary packaging services
- Analytical services and regulatory support

## Manufacturing Infrastructure

- **Total capacity:** 400,000 square feet of GMP manufacturing space across four facilities
- **Locations:** Haverhill (UK), Nottingham (UK), St. Louis (Missouri), and Seymour (Indiana)
- **Scale:** From grams to multi-ton production with seamless scale-up
- **Regulatory track record:** 30-year impeccable regulatory history

## Quality & Compliance

- Operates under rigorous cGMP standards (21 CFR Parts 210/211, 110/111, 117)
- Quality by Design (QbD) philosophy with ICH Q8/Q9/Q10 implementation
- FDA-inspected facilities with successful recent inspections (St. Louis facility passed FDA inspection in 2025)
- Manufacturing site GMP approval by German authorities
- Kaizen and Lean manufacturing principles embedded across operations
- Culture of continuous improvement and operational excellence

## Customer Base

Trusted CDMO partner for pharmaceutical, consumer health, OTC, and nutraceutical customers worldwide.

## Related companies

- [Glatt](/companies/glatt) (Formulation Development, Process Development) — [Compare](/compare/codis/glatt)
- [Bend Bioscience](/companies/societalcdmo) (Formulation Development, Process Development) — [Compare](/compare/codis/societalcdmo)
- [UPM Pharmaceuticals](/companies/upm-inc) (Formulation Development, Process Development) — [Compare](/compare/codis/upm-inc)
- [Hovione](/companies/hovione) (Formulation Development, Process Development) — [Compare](/compare/codis/hovione)
- [Metrics Contract Services](/companies/metricscontractservices) (Formulation Development, Process Development) — [Compare](/compare/codis/metricscontractservices)
- [Lupin Limited](/companies/lupin) (Formulation Development, Process Development) — [Compare](/compare/codis/lupin)
- [Quotient Sciences](/companies/quotientsciences) (Formulation Development, Process Development) — [Compare](/compare/codis/quotientsciences)
- [CMC Pharmaceuticals, Inc.](/companies/cmcpharm) (Formulation Development, Process Development) — [Compare](/compare/cmcpharm/codis)

_Profile last updated: 2026-08-05T00:02:46.731Z. Profile facts may include AI-assisted enrichment._

Auto-generated by BioBM Editorial AI for machine-readable profile access.